Skip To Main Content
Yinjun Mao on Muck Rack

Yinjun Mao

As seen in: Nature, Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinjun

Contact Yinjun, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effective fluorescent determination of tigecycline using silicon and nitrogen co-doped carbon dots as probe through inner filter effect

|
By Yinjun Mao, Qian Chen, Xian Chen, Yao Wang, Ying Zheng, Jianfeng Pan, Shaohuang Weng
| Nature Verified
Abstract Accurate and efficient determination of tigecycline is critical for pharmaceutical quality control and clinical therapeutic drug monitoring. Herein, silicon and nitrogen co-doped carbon dots (Si, N-CDs) with a high absolute quantum yield of 50.19% and excitation-independent emission were synthesized via a one-step hydrothermal method using trans-aconitic acid and N-[3-(trimethoxysilyl)propyl]ethylenediamine as precursors.
Open in Who Shared Issue with article?

Meta‐analysis of pulsed‐field ablation versus cryoablation for atrial fibrillation

|
By Hua Zhang, Heng Lu, Hehua Zhang, Yinjun Mao
| Wiley Online Library Verified
Purpose The available data on the treatment strategy of pulsed field ablation (PFA) for patients with atrial fibrillation (AF) is limited. This study aims to provide a comparative analysis of the efficacy, safety, and procedural efficiency between PFA and cryoballoon ablation (CBA) for AF. Methods We conducted a comprehensive search of the EMBASE, PubMed, Cochrane Library, and ClinicalTrials.gov databases to identify trials comparing PFA with CBA for AF from their inception until December 2023.
Open in Who Shared Issue with article?
See all 2 articles